ANANDAMIDE

  • CAS No.: 94421-68-8
  • Purity: 99%
Contact us

Quality Factory Hot Selling ANANDAMIDE 94421-68-8 with Fast Shipping

  • Molecular Formula: C22H37 N O2
  • Molecular Weight: 347.541
  • Appearance/Colour: light yellow oil 
  • Vapor Pressure: 4.33E-13mmHg at 25°C 
  • Boiling Point: 522.3 ºCat 760 mmHg 
  • PKA: 14.48±0.10(Predicted) 
  • Flash Point: 269.7 ºC 
  • PSA: 49.33000 
  • Density: 0.92 g/mL at 25 °C(lit.) 
  • LogP: 5.63150 

ANANDAMIDE(Cas 94421-68-8) Usage

Hazard

A reproductive hazard.

Biological Activity

Endogenous cannabinoid and vanilloid receptor agonist, in water-soluble emulsion (for details see TocrisolveTM 100). K i values are 89 and 371 nM for CB 1 and CB 2 receptors respectively; EC 50 values are 18, 31 and 27 nM at GPR55, CB 1 and CB 2 respectively; pK i = 5.68 for rVR1. Also blocks TNF- α -induced NF-kB activation via direct inhibition of IKK. Also available as the pure oil dissolved in ethanol (N-(2-Hydroxyethyl)-5Z,8Z,11Z,14Z-eicosatetraenamide ).

Biochem/physiol Actions

An arachidonic acid derivative that is an endogenous ligand for the CB cannabinoid receptor and for the VR1 vanilloid receptor. Inhibits calcium currents in neuroblastomas and neurons. Activates the MAP kinase signaling pathway. Inhibits proliferation and induces apoptosis of lymphocytes and human breast cancer cells.

Enzyme inhibitor

This lipid neurotransmitter and endocannabinoid receptor ligand (FW = 347.54 g/mol; CAS 94421-68-8), also known as arachidonylethanolamide, inhibits calcium ion currents and activates the MAP kinase signaling pathway. Anandamide is a naturally occurring effector of central and peripheral nervous systems, as mediated by CB1 and CB2 cannabinoid receptors, respectively. (These receptors were originally characterized as binding Δ9 -tetrahydrocannabinol, or THC, marijuana’s major psychoactive ingredient.) Anandamide, 2-arachidonoylglycerol, and congeners (N- oleoylethanolamide and N-palmitoylethanolamide) are lipophilic signalling molecules with multiple physiological roles in learning and memory, neuroinflammation, oxidative stress, neuroprotection and neurogenesis. Anandamide likewise plays a role in regulating uterine implantation of the early-stage embryo (blastocyst). Anandamide synthesis occurs from N- acetylphosphatidylethanolamine by multiple pathways that include phospholipase A2, phospholipase C, and NAPE-hydrolyzing phospholipase D (or NAPE-PLD). Target(s): adenylate cyclase; Na + channels; a7-nicotinic acetylcholine receptor; 5 HT3 receptors; Ca 2+ channels; K+ channels, voltage-gated; acylglycerol lipase, or monoacylglycerol lipase.

General Description

Anandamide, also known as arachidonylethanolamide or N-arachidonoylethanolamine, is an endogenous cannabinoid receptor ligand that exhibits structural and functional similarities to Δ9-tetrahydrocannabinol (THC). Research highlights its stereochemical selectivity for CB1 and CB2 receptors, with modifications such as methyl group substitutions enhancing receptor affinity, particularly for CB1, while offering limited improvements in metabolic stability. Hybrid analogs combining structural features of anandamide and THC demonstrate high binding affinity, suggesting shared pharmacophoric elements critical for cannabinoid receptor interaction. These findings underscore anandamide's role as a key endocannabinoid and its potential as a template for designing novel cannabinoid receptor modulators.

Definition

ChEBI: An N-(polyunsaturated fatty acyl)ethanolamine resulting from the formal condensation of carboxy group of arachidonic acid with amino group of ethanolamine.

InChI:InChI=1/C22H37NO2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-22(25)23-20-21-24/h6-7,9-10,12-13,15-16,24H,2-5,8,11,14,17-21H2,1H3,(H,23,25)/b7-6-,10-9-,13-12-,16-15-

94421-68-8 Relevant articles

Modification of the antitumor effect of doxorubicin by complexes of α-fetoprotein with amphiphilic compounds based on polyenoic fatty acids

Arsenov,Babitskaya,Vashkevich,Golubeva,Kisel,Kuz'mitskii,Mashkovich,Slabkevich,Strel'chenok

, p. 474 - 477 (2002)

-

Enrichment of arachidonic acid for the enzymatic synthesis of arachidonoyl ethanolamide

Wang, Xingguo,Wang, Xiaosan,Wang, Tong

, p. 1031 - 1039 (2013)

Arachidonoyl ethanolamide is an endogeno...

Methyl arachidonyl fluorophosphonate: A potent irreversible inhibitor of anandamide amidase

Deutsch, Dale G.,Omeir, Romelda,Arreaza, Gladys,Salehani, David,Prestwich, Glenn D.,Huang, Zheng,Howlett, Allyn

, p. 255 - 260 (1997)

Anandamide amidase (EC 3.5.1.4) is respo...

ANANDAMIDE COMPOUNDS

-

Page/Page column 42-43, (2020/07/25)

The present application provides anandam...

COMPOSITIONS HAVING AN AGENT AND AN ENHANCER THEREOF, METHODS OF USE, AND DELIVERY SYSTEMS

-

, (2020/03/23)

The present invention relates to composi...

A Convenient Protocol for the Synthesis of Fatty Acid Amides

Johansson, Silje J. R.,Johannessen, Tonje,Ellefsen, Christiane F.,Ristun, Mali S.,Antonsen, Simen,Hansen, Trond V.,Stenstrom, Yngve,Nolsoe, Jens M. J.

supporting information, p. 213 - 217 (2019/01/14)

Several classes of biologically occurrin...

INHIBITORS OF N-ACYLPHOSPHATIDYLETHANOLAMINE PHOSPHOLIPASE D (NAPE-PLD)

-

, (2019/12/15)

The invention relates to a compound of t...

94421-68-8 Process route

all cis 5,8,11,14-eicosatetraenoic acid
506-32-1,236743-58-1

all cis 5,8,11,14-eicosatetraenoic acid

ethanolamine
141-43-5

ethanolamine

anandamide
94421-68-8

anandamide

Conditions
Conditions Yield
all cis 5,8,11,14-eicosatetraenoic acid; With 1,1'-carbonyldiimidazole; In dichloromethane; at 20 ℃; for 0.5h;
ethanolamine; In dichloromethane; for 12h;
96%
all cis 5,8,11,14-eicosatetraenoic acid; With 1-[(1-(cyano-?2-?ethoxy-?2-?oxoethylidenaminooxy)?dimethylamino-?morpholino)]-uronium hexafluorophosphate; N-ethyl-N,N-diisopropylamine; In dichloromethane; acetonitrile; at 20 ℃; for 0.166667h; Inert atmosphere;
ethanolamine; In dichloromethane; acetonitrile; at 20 ℃; Inert atmosphere;
85%
With Candida antarctica lipase B; In hexane; at 50 ℃; for 6h; Inert atmosphere; Enzymatic reaction;
72.7%
all cis 5,8,11,14-eicosatetraenoic acid; With 1,1'-carbonyldiimidazole; In dichloromethane; at 20 ℃; for 1h; Inert atmosphere;
ethanolamine; In dichloromethane; at 20 ℃; for 2h; Inert atmosphere;
64%
With triethylamine; carbonochloridic acid, butyl ester; In tetrahydrofuran; methanol; acetonitrile; at 20 ℃; for 2h;
all cis 5,8,11,14-eicosatetraenoic acid; With oxalyl dichloride; N,N-dimethyl-formamide; In benzene; at 0 - 20 ℃; for 1h;
ethanolamine; In tetrahydrofuran; benzene; at 0 - 20 ℃;
With dmap; triethylamine; dicyclohexyl-carbodiimide;
With dmap; triethylamine; dicyclohexyl-carbodiimide; In dichloromethane; at 25 ℃; for 24h;
all cis 5,8,11,14-eicosatetraenoic acid; With dmap; benzotriazol-1-ol; In dichloromethane; at 0 - 20 ℃; for 0.5h;
With 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride; In dichloromethane; at 0 - 20 ℃; for 3h;
ethanolamine; at 20 ℃; for 16h;
3.8g
ethanolamine
141-43-5

ethanolamine

arachidonoyl chloride
57303-04-5

arachidonoyl chloride

anandamide
94421-68-8

anandamide

Conditions
Conditions Yield
94%
In dichloromethane; at 20 ℃; for 1h; Cooling with ice;
92%
In tetrahydrofuran; N,N-dimethyl-formamide; for 0.25h; Yield given; Ambient temperature;
In dichloromethane; at 25 ℃;

94421-68-8 Upstream products

  • 141-43-5
    141-43-5

    ethanolamine

  • 57303-04-5
    57303-04-5

    arachidonoyl chloride

  • 506-32-1
    506-32-1

    all cis 5,8,11,14-eicosatetraenoic acid

  • 2002-24-6
    2002-24-6

    2-amino-ethanol hydrochloride

94421-68-8 Downstream products

  • 287937-12-6
    287937-12-6

    virodhamine

  • 79551-85-2
    79551-85-2

    19-Hydroxyarachidonic acid

  • 184488-43-5
    184488-43-5

    4-{3-[(2Z,5Z,8Z)-tetradeca-2,5,8-trienyl]oxiran-2-yl}butanoic acid

  • 184488-44-6
    184488-44-6

    8,9-epoxyeicosa-5(Z),11(Z),14(Z)-trienoic acid

*Product Name
CasNo
Purity
Quantity
Company name
*Email
*Other Description
*Verification code:
Submit
Purchase Posted Successfully, our staff will contact you within 24 hours.